APPROVALS

Axovant Sciences has licensed exclusive worldwide rights for the development and commercialisation of two novel gene therapy programs to address GM1 gangliosidosis and GM2...

Novartis has this week secured approval in Europe for Xolair prefilled syringe for self-administration. The treatment allows patients with severe allergic asthma (SAA) and chronic...

Bausch Health Companies has acquired biopharma Synergy Pharmaceuticals out of bankruptcy for $200 million. News of the acquisition comes as the beleaguered company filed a...